おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SmartNuclide
company
About
SmartNuclide is a biopharmaceutical company that develops biological drug products.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥10M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Sep 25, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥33M
SmartNuclide has raised a total of
¥33M
in funding over 2 rounds. Their latest funding was raised on
Apr 23, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 23, 2020 | Series B | ¥20M | 2 |
|
— | Detail |
| Feb 2, 2018 | Series A | ¥10M | 2 | — | — | Detail |
| Mar 21, 2016 | Angel | ¥3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
5
SmartNuclide is funded by 5 investors.
Ruihe Zichan
and Xieyao Kexin Chuangye Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series B |
|
|
— | Series B |
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
